日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial

一项随机试验中,癌症干细胞检测指导化疗可提高复发性胶质母细胞瘤患者的生存率

Tulika Ranjan, Soma Sengupta, Michael J Glantz, Richard M Green, Alexander Yu, Dawit Aregawi, Rekha Chaudhary, Ricky Chen, Mario Zuccarello, Christine Lu-Emerson, Hugh D Moulding, Neil Belman, Jon Glass, Aaron Mammoser, Mark Anderson, Jagan Valluri, Nicholas Marko, Jason Schroeder, Steven Jubelirer,

Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL

利索卡巴吉内马拉鲁塞与标准治疗在复发或难治性大B细胞淋巴瘤中的健康相关生活质量比较

Abramson, Jeremy S; Johnston, Patrick B; Kamdar, Manali; Ibrahimi, Sami; Izutsu, Koji; Arnason, Jon; Glass, Bertram; Mutsaers, Pim; Lunning, Matthew; Braverman, Julia; Liu, Fei Fei; Crotta, Alessandro; Montheard, Sandrine; Previtali, Alessandro; Guo, Shien; Shi, Ling; Solomon, Scott R

A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas

索拉非尼联合替莫唑胺和放射疗法治疗原发性和复发性高级别胶质瘤的 I 期研究

Robert B Den, Mitchell Kamrava, Zhi Sheng, Maria Werner-Wasik, Erin Dougherty, Michelle Marinucchi, Yaacov R Lawrence, Sarah Hegarty, Terry Hyslop, David W Andrews, Jon Glass, David P Friedman, Michael R Green, Kevin Camphausen, Adam P Dicker